O

OMass Therapeutics

Develops small-molecule therapeutics for GPCRs

Discovery DMPK Scientist – Senior Scientist 2 / Principal Scientist

Quantitative Biology & BiostatisticsPosted on Nov 11
Full-timeOxford, UK

About the Job

Requirements

  • A degree or PhD in Biology, Chemistry, Pharmacy, Pharmacokinetics, or a related pharmaceutical science.
  • Significant relevant pharmaceutical industry, biotechnology, and/or contract research organization experience, with a track record of contributing DMPK expertise from early discovery through preclinical or first-in-human work.
  • Strong knowledge of DMPK science, including in vitro ADME, in silico ADME, and bioanalysis.
  • Experience overseeing assay work with contract research organizations or internal laboratories, including protocol design and data interpretation.
  • Technical expertise and demonstrated application of in vivo pharmacokinetic modeling, IVIVE, and human dose prediction in support of drug discovery and development.
  • High-level analytical and problem-solving skills and the ability to think laterally.
  • A caring and inclusive approach, with respect and receptiveness to others’ diverse ideas, experience, and perspectives, and the ability to work collaboratively as part of a team.
  • Excellent written and verbal communication skills and strong attention to detail.

Responsibilities

  • Provide DMPK expertise to drug discovery projects across hit-to-lead, lead optimization, and candidate selection.
  • Work with medicinal chemistry, pharmacology, and bioscience colleagues to resolve or mitigate project-related DMPK challenges in the design and optimization of drug discovery molecules.
  • Design, commission, and oversee experimental studies through specialist contract research organizations to support compound optimization, project progression, and candidate selection, and to understand and resolve project ADME challenges.
  • Translate in vitro ADME data and preclinical pharmacokinetics into predictions of pharmacokinetics and safety in patients.
  • Develop mechanistic and pharmacokinetic/pharmacodynamic models to evaluate hypotheses, optimize study design, and support project progression.
  • Interpret data and write and present project reports.
  • Share information openly and collaborate with other departments to advance projects and achieve company goals.
  • Represent DMPK on multidisciplinary projects and provide scientific leadership, bringing a fresh perspective and enthusiasm to tackle new challenges and learn new skills.
  • Promote and adhere to OMass’ values of being ambitious, responsible, innovative, focused, caring, and collaborative.

Desired Qualifications

  • Ability to navigate and work effectively in a fast-paced, matrix-team environment.
  • Expertise and demonstrated application of pharmacokinetic/pharmacodynamic methods and concepts in support of drug discovery.
  • Experience managing and working with external contract research organizations.
  • Strong understanding of drug-discovery disciplines such as target validation and pharmacology, and experience in early development areas such as drug safety/toxicology and pharmaceutics.
  • Creative and strategic thinking, with the ability to enthuse the DMPK group and wider OMass team with innovative ideas.
  • Strong organizational skills, ability to prioritize work according to project goals, and responsibility for timely delivery of objectives.

About the Company

OMass Therapeutics

Develops small-molecule therapeutics for GPCRs

OMass Therapeutics develops small molecule drugs for hard-to-drug targets. It uses its OdyssION platform, which combines novel biochemistry techniques, native mass spectrometry, and custom chemistry to study how a protein behaves in its native ecosystem and to identify drug candidates that modulate target activity. The company focuses on rare diseases and immunology, targeting solute carriers, complex-bound proteins, and GPCRs, and aims to build a pipeline and then partner with larger pharmaceutical firms for later-stage development and commercialization. Compared with competitors, OMass emphasizes ecosystem-aware target engagement and direct analysis of proteins in their native context through native MS, enabling discovery against intractable targets that are not easily drugged by conventional methods. Its goal is to deliver a portfolio of small molecule therapeutics and collaborate with larger players to bring drugs to market.

Company size
51-200
Company stage
Series C
Total funding
$479.7M
Headquarters
Oxford, United Kingdom
Founded
2016

Recently Posted Jobs

Explore more opportunities at OMass Therapeutics

See more jobs